Pharmaceutical Lobbyist Dick Armey Inspires GOP To Obstruct Health Care Reform

May 20, 2009 7:03 pm ET

On May 20, 2009, former House Majority Leader and current healthcare lobbyist Dick Armey tweeted that he had given a talk to the House GOP about stopping President Obama's healthcare plans.

Dick Armey Gives House Republicans A Pep Talk


Dick Armey: Just gave talk to house gop on stopping Obamacare. The team is fired up to stop this mess. [Twitter, 5/20/09]

Dick Armey Is A Lobbyist For The Pharmaceutical Industry

Fact: Dick Armey is registered as a lobbyist for Medicines Co. [Opensecrets.org, Accessed 5/20/2009]

Medicines Co. Has Paid DLA Piper, Dick Armey's Firm, $5,860,000 Since 2005.

In 2009 Medicine Co. has already paid Dick Armey's firm DLA Piper $590,000. [Opensecrets.org, accessed 5/20/2009]

In 2008 Medicine Co. paid Dick Armey's firm DLA Piper $1,530,000. [Opensecrets.org, accessed 5/20/2009]

In 2007 Medicine Co. paid Dick Armey's firm DLA Piper $1,300,000. [Opensecrets.org, accessed 5/20/2009]

In 2006 Medicine Co. paid Dick Armey's firm DLA Piper $1,700,000. [Opensecrets.org, accessed 5/20/2009]

In 2005 Medicine Co. paid Dick Armey's firm DLA Piper $740,000. [Opensecrets.org, accessed 5/20/2009]

According To The Company's Website, Medicines Co.:

The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU-2010, in early-stage development. Through the acquisition of Targanta Therapeutics Corporation, The Medicines Company's pipeline also includes oritavancin, a semi-synthetic lipoglycopeptide antibiotic in late-stage development in the United States and currently awaiting EU regulatory approval. [TheMedicinesCompany.com, accessed 5/20/09]

Other DLA Piper Clients Include Numerous Corporations Opposed to President Obama's Reforms.  According to the federal lobbying disclosure database, past and current DLA Piper clients include:

  • Alliant Energy Corporation
  • American Council of Life Insurers
  • American Financial Group
  • American Insurance Association
  • AIG
  • BP America
  • Bristol-Myers Squibb
  • China Chamber of Commerce
  • Clarendon Insurance Group
  • Constellation Energy Group
  • Dubai Group
  • DuPont Corporation
  • Edison Electric
  • Emirates Investment and Development
  • First Kuwaiti General Trading & Contracting Company
  • General Motors
  • Goldman Sachs & Co.
  • Irving Oil
  • Lehman Bros. Inc.
  • Merrill Lynch
  • Residential Loan Centers of America
  • TransGas Energy
  • Vitas Healthcare Corporation
  • Washington Group International
  • World Fuel Services Corporation

[Senate Lobbying Disclosure Act Database, accessed 4/16/09]

Print